HopeStage
Back to all studies
CompletedNCT00453804

Long-acting or oral naltrexone for alcohol dependence with serious mental illness

About this titleRead the official source — NCT00453804
Medication studyAges 18–69United StatesSchizophrenia
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 69 years.

Listed locations
SyracuseSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateJuly 2006
Recruitment status
Completed
Enrollment listed in the registry
15
Sponsor
State University of New York - Upstate Medical University
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
From 18 Years to 69 Years
Official registry ID
NCT00453804
Official title
Show the full official title

Injectable Versus Oral Naltrexone Treatment of Alcohol Dependence In Serious Mental Illness (SMI): A Pilot Study

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Syracuse

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is State University of New York - Upstate Medical University, a university.

Did this study involve medication?

Yes. The study involved medication, including injectable naltrexone and oral naltrexone.

Who was this study for?

Listed age limits: 18 years to 69 years.

Want to explore more studies?

Explore studies